FDA Inspection
Jiangsu Baozong & Baoda Pharmachem Co., Ltd.Jiangsu Baozong & Baoda Pharmachem Co., Ltd. – FDA Inspection, Jun 21, 2019
Record Details
This FDA Inspection record concerns Jiangsu Baozong & Baoda Pharmachem Co., Ltd., with an inspection on June 21, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6e05b5aa-f083-4638-a064-38da25093458
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1096225
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Jiangsu Baozong & Baoda Pharmachem Co., Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 28, 2025 | Not classified | Office of Inspections and Investigations | |
| August 10, 2018 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| April 15, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 23, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Jiangsu Baozong & Baoda Pharmachem Co., Ltd.
- FDA Inspection 1266874 - 2025-03-28
- FDA Inspection 1064318 - 2018-08-10
- FDA Inspection 966933 - 2016-04-15
- FDA Inspection 890701 - 2014-07-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.